ofloxacin has been researched along with Group A Strep Infection in 56 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this open-label, single-arm, multicenter study was to assess the efficacy and safety of levofloxacin in the treatment of complicated urinary tract infections." | 9.10 | [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections]. ( Marchetti, F; Trinchieri, A, 2003) |
| "Endogenous endophthalmitis is a rare complication of infective endocarditis and has been decreasing due to the availability of effective antibiotics." | 5.35 | Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis. ( Dinani, A; Ktaich, N; Rubin, D; Urban, C, 2009) |
| "The objective of this open-label, single-arm, multicenter study was to assess the efficacy and safety of levofloxacin in the treatment of complicated urinary tract infections." | 5.10 | [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections]. ( Marchetti, F; Trinchieri, A, 2003) |
| " In a prospective, randomized, open trial, we evaluated the efficacy and safety of oral roxithromycin (150 mg twice daily) as additional antibacterial prophylaxis in 131 adult patients with acute leukemia and bone marrow transplant recipients receiving oral ofloxacin." | 5.07 | A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. ( Arnold, R; Hay, B; Kern, P; Kern, WV; Marre, R, 1994) |
| "Ofloxacine (Tarivid-Hoechst) was used in 30 patients with infections of the respiratory system, including 12 with pneumonias, 18 with chronic bronchitis." | 3.68 | [Evaluation of the effectiveness of ofloxacin in the treatment of respiratory tract]. ( Chyrek-Borowska, S; Jakubicz, P; Siergiejko, Z, 1991) |
| " In contrast, a small number of levofloxacin-resistant streptococci were observed at the end of dosing but decreased by week 2 post-dosing and continued to decrease through the 6-week evaluation period (p < 0." | 2.74 | Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial- resistant streptococci in the microflora of healthy adults. ( Ambruzs, M; Fisher, AC; Nord, CE; Peterson, J, 2009) |
| " Drug-related adverse events were reported by 8." | 2.69 | A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections. ( Jasovich, A; Neto, W; Nicodemo, AC; Robledo, JA, 1998) |
| "Ofloxacin was administered at a dose of 200 mg every 12 hours for a mean duration of ten days." | 2.66 | [Efficacy of injectable ofloxacin in treating septicemia. Multicenter study]. ( Doco-Lecompte, T; Modaï, J, 1989) |
| "We present a case of septic arthritis of the TMJ following the extraction of the left upper second molar that occurred 1 week before beginning of symptoms." | 2.44 | Septic arthritis of the temporomandibular joint successfully treated with arthroscopic lysis and lavage: case report and review of the literature. ( Albiero, AM; Costa, F; Politi, M; Robiony, M; Sembronio, S; Toro, C, 2007) |
| " Pharmacodynamic principles can also be used to devise the optimal administration regimen for specific antimicrobial agents." | 2.41 | Pharmacodynamics and pharmacokinetics of levofloxacin. ( Grant, EM; Nightingale, CH; Quintiliani, R, 2000) |
| " FQs at proper dosage can be effective against S." | 1.39 | Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes. ( Balaji, K; Pandian, SK; Thenmozhi, R, 2013) |
| "Endogenous endophthalmitis is a rare complication of infective endocarditis and has been decreasing due to the availability of effective antibiotics." | 1.35 | Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis. ( Dinani, A; Ktaich, N; Rubin, D; Urban, C, 2009) |
| "We present the case of a patient with ADPKD and suspected cyst infection caused by group B streptococcus who was treated successfully with levofloxacin and ampicillin." | 1.33 | Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease. ( Hiyama, L; Miller, LG; Tang, A, 2006) |
| "Levofloxacin was also quite active, inhibiting 98-100% of the isolates at concentrations < or = 2 micrograms/ml." | 1.30 | Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin. ( Jones, RN; Pfaller, MA, 1997) |
| "HSR-903 was active against experimental respiratory tract infections in mice challenged with penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae and Haemophilus influenzae strains." | 1.30 | In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens. ( Domon, H; Miyazaki, S; Yamaguchi, K; Yoshizumi, S, 1998) |
| "Levofloxacin was no more effective than penicillin against the penicillin-resistant strain." | 1.30 | Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. ( Chambers, HF; Chow, LL; Hackbarth, C; Xiang, Q, 1999) |
| "Levofloxacin was investigated against viridans group streptococci in vitro and in rats with experimental aortic endocarditis." | 1.30 | Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci. ( Caldelari, I; Entenza, JM; Glauser, MP; Moreillon, P, 1999) |
| "Against respiratory tract infections with K." | 1.28 | In vivo evaluation of NM441, a new thiazeto-quinoline derivative. ( Kimura, K; Kise, M; Kitano, M; Matsuda, M; Nishino, T; Otsuki, M; Ozaki, M; Segawa, J; Shibata, K; Tomii, Y, 1991) |
| "Ofloxacin was active against all but one (Pseudomonas aeruginosa) blood culture isolates." | 1.27 | Comparative activity of ofloxacin with reference to bacterial strains isolated in in-patients and out-patients. ( Alkan, M; Berger, S; Bogokowski, B; Keren, G; Mark, Z; Rubinstein, E, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.36) | 18.7374 |
| 1990's | 18 (32.14) | 18.2507 |
| 2000's | 25 (44.64) | 29.6817 |
| 2010's | 10 (17.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyamoto, T | 1 |
| Matsumoto, J | 1 |
| Chiba, K | 1 |
| Egawa, H | 1 |
| Shibamori, K | 1 |
| Minamida, A | 1 |
| Nishimura, Y | 1 |
| Okada, H | 1 |
| Kataoka, M | 1 |
| Fujita, M | 1 |
| Montes, M | 1 |
| Tamayo, E | 1 |
| Orden, B | 1 |
| Larruskain, J | 1 |
| Perez-Trallero, E | 1 |
| Chan, E | 1 |
| Ayres, M | 1 |
| Balaji, K | 1 |
| Thenmozhi, R | 1 |
| Pandian, SK | 1 |
| O'Connor, KM | 1 |
| Williams, P | 1 |
| Pergam, SA | 1 |
| Wajima, T | 1 |
| Murayama, SY | 1 |
| Sunaoshi, K | 1 |
| Nakayama, E | 1 |
| Sunakawa, K | 1 |
| Ubukata, K | 1 |
| Gracia, M | 1 |
| Díaz, C | 1 |
| Coronel, P | 1 |
| Gimeno, M | 1 |
| García-Rodas, R | 1 |
| Rodríguez-Cerrato, V | 1 |
| del Prado, G | 1 |
| Huelves, L | 1 |
| Ruiz, V | 1 |
| Naves, PF | 1 |
| Ponte, MC | 1 |
| Granizo, JJ | 1 |
| Soriano, F | 1 |
| Aggarwal, H | 1 |
| Smith, AD | 1 |
| Kuo, PC | 1 |
| Vikraman, DS | 1 |
| Nord, CE | 1 |
| Peterson, J | 1 |
| Ambruzs, M | 1 |
| Fisher, AC | 1 |
| Dinani, A | 1 |
| Ktaich, N | 1 |
| Urban, C | 1 |
| Rubin, D | 1 |
| Llaneza, E | 1 |
| Seral, C | 1 |
| Castillo, FJ | 1 |
| Durán, E | 1 |
| Rubio-Calvo, C | 1 |
| Gómez-Lus, R | 1 |
| Köller, T | 1 |
| Manetti, AGO | 1 |
| Kreikemeyer, B | 1 |
| Lembke, C | 1 |
| Margarit, I | 1 |
| Grandi, G | 1 |
| Podbielski, A | 1 |
| Orr, D | 1 |
| Wilkinson, P | 1 |
| Moyce, L | 1 |
| Martin, S | 1 |
| George, R | 1 |
| Pichon, B | 1 |
| Pinho, MD | 1 |
| Melo-Cristino, J | 1 |
| Ramirez, M | 1 |
| Salman, S | 1 |
| Young, M | 1 |
| Van Sickels, JE | 1 |
| Lorenzo Garde, L | 1 |
| Bolaños Rivero, M | 1 |
| Turégano García, Á | 1 |
| Martín Sánchez, AM | 1 |
| Treszezamsky, AD | 1 |
| Feldman, D | 1 |
| Sarabanchong, VO | 1 |
| Wang, H | 1 |
| Zhao, C | 1 |
| He, W | 1 |
| Zhang, F | 1 |
| Zhang, L | 1 |
| Cao, B | 1 |
| Sun, Z | 1 |
| Xu, Y | 1 |
| Yang, Q | 1 |
| Mei, Y | 1 |
| Hu, B | 1 |
| Chu, Y | 1 |
| Liao, K | 1 |
| Yu, Y | 1 |
| Hu, Z | 1 |
| Ni, Y | 1 |
| Richter, SS | 1 |
| Diekema, DJ | 1 |
| Heilmann, KP | 1 |
| Almer, LS | 1 |
| Shortridge, VD | 1 |
| Zeitler, R | 1 |
| Flamm, RK | 1 |
| Doern, GV | 1 |
| Trinchieri, A | 1 |
| Marchetti, F | 1 |
| Rodríguez-Zurita, ME | 1 |
| Solís del Baño, S | 1 |
| Robres Guillén, P | 1 |
| González Praetorius, A | 1 |
| Gimeno Fernández, C | 1 |
| Pérez Pomata, MT | 1 |
| Bisquert Santiago, J | 1 |
| Mulla, ZD | 1 |
| Entenza, JM | 2 |
| Vouillamoz, J | 1 |
| Glauser, MP | 2 |
| Moreillon, P | 2 |
| Barequet, IS | 1 |
| Denton, P | 1 |
| Osterhout, GJ | 1 |
| Tuli, S | 1 |
| O'Brien, TP | 1 |
| Reinert, RR | 1 |
| Lütticken, R | 1 |
| Al-Lahham, A | 1 |
| Bloom, C | 1 |
| Thomson, EC | 1 |
| Main, J | 1 |
| Rivera, A | 1 |
| Rebollo, M | 1 |
| Sánchez, F | 1 |
| Navarro, F | 1 |
| Miró, E | 1 |
| Mirelis, B | 1 |
| Coll, P | 1 |
| Hiyama, L | 1 |
| Tang, A | 1 |
| Miller, LG | 1 |
| Sembronio, S | 1 |
| Albiero, AM | 1 |
| Robiony, M | 1 |
| Costa, F | 1 |
| Toro, C | 1 |
| Politi, M | 1 |
| Mollerach, A | 1 |
| Méndez, E | 1 |
| Massa, R | 1 |
| Di Conza, J | 1 |
| Alonso, R | 1 |
| Mateo, E | 1 |
| Ezpeleta, G | 1 |
| Cisterna, R | 1 |
| Tazi, A | 1 |
| Gueudet, T | 1 |
| Varon, E | 1 |
| Gilly, L | 1 |
| Trieu-Cuot, P | 1 |
| Poyart, C | 1 |
| Brook, I | 2 |
| Tom, SP | 1 |
| Ledney, GD | 2 |
| Kern, WV | 1 |
| Hay, B | 1 |
| Kern, P | 1 |
| Marre, R | 1 |
| Arnold, R | 1 |
| Bow, EJ | 1 |
| Mandell, LA | 1 |
| Louie, TJ | 1 |
| Feld, R | 1 |
| Palmer, M | 1 |
| Zee, B | 1 |
| Pater, J | 1 |
| Plouffe, JF | 1 |
| Spanik, S | 1 |
| Trupl, J | 1 |
| Kunova, A | 1 |
| Botek, R | 1 |
| Sorkovska, D | 1 |
| Grey, E | 1 |
| Studena, M | 1 |
| Lacka, J | 1 |
| Oravcova, E | 1 |
| Krchnakova, A | 1 |
| Rusnakova, V | 1 |
| Svec, J | 1 |
| Krupova, I | 1 |
| Grausova, S | 1 |
| Stopkova, K | 1 |
| Koren, P | 1 |
| Krcmery, V | 2 |
| Pfaller, MA | 1 |
| Jones, RN | 1 |
| Tuohy, M | 1 |
| Washington, JA | 1 |
| Yoshizumi, S | 1 |
| Domon, H | 1 |
| Miyazaki, S | 1 |
| Yamaguchi, K | 1 |
| Nicodemo, AC | 1 |
| Robledo, JA | 1 |
| Jasovich, A | 1 |
| Neto, W | 1 |
| Akiyama, H | 1 |
| Yamasaki, O | 1 |
| Kanzaki, H | 1 |
| Tada, J | 1 |
| Arata, J | 1 |
| Krupova, Y | 1 |
| Novotny, J | 1 |
| Sabo, A | 1 |
| Mateicka, F | 1 |
| Prenna, M | 1 |
| Montanari, MP | 1 |
| Mingoia, M | 1 |
| Biavasco, F | 1 |
| Ripa, S | 1 |
| Varaldo, PE | 1 |
| Chambers, HF | 1 |
| Xiang, Q | 1 |
| Chow, LL | 1 |
| Hackbarth, C | 1 |
| Caldelari, I | 1 |
| Nightingale, CH | 1 |
| Grant, EM | 1 |
| Quintiliani, R | 1 |
| Lin, FY | 1 |
| Azimi, PH | 1 |
| Weisman, LE | 1 |
| Philips, JB | 1 |
| Regan, J | 1 |
| Clark, P | 1 |
| Rhoads, GG | 1 |
| Clemens, J | 1 |
| Troendle, J | 1 |
| Pratt, E | 1 |
| Brenner, RA | 1 |
| Gill, V | 1 |
| Remacha Esteras, M | 1 |
| Herrera Rubio, J | 1 |
| Parra Parra, I | 1 |
| Rodríguez-Avial, I | 1 |
| Rodríguez-Avial, C | 1 |
| Picazo, JJ | 1 |
| Ozaki, M | 1 |
| Matsuda, M | 1 |
| Tomii, Y | 1 |
| Kimura, K | 1 |
| Segawa, J | 1 |
| Kitano, M | 1 |
| Kise, M | 1 |
| Shibata, K | 1 |
| Otsuki, M | 1 |
| Nishino, T | 1 |
| Chyrek-Borowska, S | 1 |
| Siergiejko, Z | 1 |
| Jakubicz, P | 1 |
| Doco-Lecompte, T | 1 |
| Modaï, J | 1 |
| Sugimoto, R | 1 |
| Satoh, T | 1 |
| Rubinstein, E | 1 |
| Mark, Z | 1 |
| Keren, G | 1 |
| Alkan, M | 1 |
| Berger, S | 1 |
| Bogokowski, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Open-Label Study Comparing Levofloxacin Once-Daily 750 mg PO for 5 Days and Azithromycin Once-Daily 500 mg on Day One and Then 250 mg Days 2 Through 5 In a Microbiologic Evaluation for Emergence of Resistance in the Oropharyngeal Flora of He[NCT00821782] | Phase 1 | 143 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ofloxacin and Group A Strep Infection
| Article | Year |
|---|---|
Septic arthritis of the temporomandibular joint successfully treated with arthroscopic lysis and lavage: case report and review of the literature.
Topics: Amoxicillin; Anti-Bacterial Agents; Arthritis, Infectious; Arthroscopy; Drainage; Female; Humans; Mi | 2007 |
Pharmacodynamics and pharmacokinetics of levofloxacin.
Topics: Anti-Infective Agents; Area Under Curve; Cost-Benefit Analysis; Cross Infection; Drug Costs; Humans; | 2000 |
6 trials available for ofloxacin and Group A Strep Infection
| Article | Year |
|---|---|
Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial- resistant streptococci in the microflora of healthy adults.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Resis | 2009 |
[Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
Topics: Anti-Infective Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Enterobacteriaceae | 2003 |
A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bone Marrow Transplantation; Cyclospo | 1994 |
Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
Topics: Adult; Aged; Anti-Infective Agents; Antineoplastic Agents; Bacteremia; Colony Count, Microbial; Fema | 1996 |
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Huma | 1998 |
[Efficacy of injectable ofloxacin in treating septicemia. Multicenter study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Gram-Negative Bacteria; Humans; Injections, Intr | 1989 |
48 other studies available for ofloxacin and Group A Strep Infection
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Male; Mice; Micro | 1990 |
Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
Topics: Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Ba | 2010 |
Corneal Perforation With Iris Plugging.
Topics: Anti-Bacterial Agents; Corneal Perforation; Cyanoacrylates; Eye Infections, Bacterial; Humans; Iris | 2018 |
Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Se | 2013 |
An unusual case of knee pain: pseudogout and Abiotrophia defectiva infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Infectious; Calcium Pyrophosphate; Ceftriaxone; | 2008 |
Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Bacterial; Bacterial Outer Membrane Proteins; | 2008 |
Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Child; Drug Resistance, Bacterial; Europe; Female; Human | 2009 |
Streptococcus equi primary bacteremia in a hepatitis-C cirrhotic patient.
Topics: Anti-Bacterial Agents; Bacteremia; Hepatitis C; Humans; Liver Cirrhosis; Male; Middle Aged; Ofloxaci | 2009 |
Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis.
Topics: Aged; Aged, 80 and over; Drug Resistance, Bacterial; Echocardiography; Endocarditis, Subacute Bacter | 2009 |
Characterization of clinical blood isolates of Streptococcus agalactiae with reduced susceptibility to levofloxacin.
Topics: Agglutination Tests; Anti-Bacterial Agents; Humans; Levofloxacin; Microbial Sensitivity Tests; Oflox | 2009 |
Typing of the pilus-protein-encoding FCT region and biofilm formation as novel parameters in epidemiological investigations of Streptococcus pyogenes isolates from various infection sites.
Topics: Bacterial Typing Techniques; Biofilms; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Fiel | 2010 |
Incidence and epidemiology of levofloxacin resistance in Streptococcus pneumoniae: experience from a tertiary referral hospital in England.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; bet | 2010 |
Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, B | 2010 |
Osteomyelitis after bilateral sagittal split osteotomy: case report and a review of the management.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Bone Plates; Bone Screws; Clindamycin; Drainage; Enterob | 2011 |
[Intraperitoneal abscess for Eikenella corrodens].
Topics: Abdominal Abscess; Adenocarcinoma; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacteri | 2011 |
Concurrent postpartum uterine and abdominal wall dehiscence and Streptococcus anginosus infection.
Topics: Abdominal Wall; Acute Disease; Adolescent; Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Cesarean | 2011 |
High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Clindamycin; DNA Gyrase; DNA Topoisomerase IV | 2013 |
Fluoroquinolone resistance in Streptococcus pyogenes.
Topics: Amino Acid Substitution; Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, B | 2003 |
[Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; | 2003 |
Group A streptococcal pneumonia.
Topics: Anti-Infective Agents; Florida; Humans; Ofloxacin; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; En | 2004 |
Treatment of experimental bacterial keratitis with topical trovafloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Col | 2004 |
High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
Topics: Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroq | 2004 |
An elderly lady with sudden blindness and a sore foot.
Topics: Administration, Topical; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blindness; Ceftriaxon | 2006 |
Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.
Topics: Amino Acid Substitution; Anti-Infective Agents; Antigens, Bacterial; Bacterial Outer Membrane Protei | 2005 |
Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Biological Availability; Drug Therapy, Combination; Female | 2006 |
[Streptococcus agalactiae isolated in Santa Fe, Argentina: antibiotic susceptibility and erythromycin-clindamycin resistance mechanisms].
Topics: Ampicillin; Argentina; Bacterial Proteins; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythr | 2007 |
Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fem | 2007 |
Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Aged, 80 and over; Anti-Bacterial Agents; Bronchitis; Chronic Disease; DNA Gyrase; Dr | 2008 |
Development of infection with Streptococcus bovis and Aspergillus sp. in irradiated mice after glycopeptide therapy.
Topics: Animals; Anti-Bacterial Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Microbial; Dr | 1993 |
Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group.
Topics: Anti-Infective Agents; Bacteremia; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin | 1996 |
Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Dru | 1997 |
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; In Vitro | 1997 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; | 1997 |
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Fluoroquinolones; Haemophilus Infections; Haemophi | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinol | 1999 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Stu | 1998 |
Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbia | 1998 |
Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
Topics: Animals; Aortic Valve; Drug Resistance, Microbial; Endocarditis, Bacterial; Heart Valve Diseases; Le | 1999 |
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Topics: Animals; Anti-Infective Agents; Catheterization; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial | 1999 |
Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Cefotaxime; Chloramphenicol; Clindamycin; Drug Resistance | 2000 |
[Bacteremic pneumonia due to Streptococcus equisimilis].
Topics: Aged; Anti-Infective Agents; Blood; Humans; Male; Ofloxacin; Pneumonia, Bacterial; Streptococcal Inf | 2001 |
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, M | 2001 |
In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Dioxolanes; Dogs; Drug Evaluati | 1991 |
[Evaluation of the effectiveness of ofloxacin in the treatment of respiratory tract].
Topics: Administration, Oral; Adult; Aged; Bronchitis; Chronic Disease; Drug Resistance, Microbial; Enteroco | 1991 |
Ofloxacin and penicillin G combination therapy in prevention of bacterial translocation and animal mortality after irradiation.
Topics: Animals; Drug Therapy, Combination; Enterobacteriaceae; Female; Liver; Mice; Mice, Inbred C3H; Oflox | 1991 |
[Bone and suppurative lesion distribution of antimicrobial agents (ampicillin and ofloxacin) in experimental infected rabbits].
Topics: Ampicillin; Animals; Bacteroides Infections; Mandibular Diseases; Ofloxacin; Rabbits; Streptococcal | 1989 |
Comparative activity of ofloxacin with reference to bacterial strains isolated in in-patients and out-patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cross Infection; Dose-Response Relationship, | 1986 |